A glance at imaging bladder cancer-Reference-Cited by-同舟云学术

A glance at imaging bladder cancer

Published:2018-05-16 Issue:4 Volume:6 Page:257-269
ISSN:2281-5872
Container-title:Clinical and Translational Imaging
language:en
Short-container-title:Clin Transl Imaging

Author:

Salmanoglu Ebru,Halpern Ethan,Trabulsi Eduoard J.,Kim Sung,Thakur Mathew L.

Funder

National Cancer Institute

Sidney Kimmel Cancer Research Center

Thomas Jefferson University

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging

Link

http://link.springer.com/article/10.1007/s40336-018-0284-9/fulltext.html

Reference81 articles.

1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–E386. https://doi.org/10.1002/ijc.29210

2. Antoni S, Ferlay J, Soerjomataram I, Znaor A, Jemal A, Bray F (2017) Bladder cancer incidence and mortality: a global overview and recent trends. Eur Urol 71:96–108. https://doi.org/10.1016/j.eururo.2016.06.010

3. National Cancer Institute. Surveillance, epidemiology, and end results program. https://seer.cancer.gov/statfacts/html/urinb.html . Accessed 1 Nov 2017

4. Svatek RS, Hollenbeck BK, Holmäng S, Lee R, Kim SP, Stenzl A, Lotan Y (2014) The economics of bladder cancer: costs and considerations of caring for this disease. Eur Urol 66:253–262. https://doi.org/10.1016/j.eururo.2014.01.006

5. Spiess PE, Agarwal N, Bangs R, Boorjian SA, Buyyounouski MK, Clark PE, Downs TM, Efstathiou JA, Flaig TW, Friedlander T, Greenberg RE, Guru KA, Hahn N, Herr HW, Hoimes C, Inman BA, Jimbo M, Kader AK, Lele SM, Meeks JJ, Michalski J, Montgomery JS, Pagliaro LC, Pal SK, Patterson A, Plimack ER, Pohar KS, Porter MP, Preston MA, Sexton WJ, Siefker-Radtke AO, Sonpavde G, Tward J, Wile G, Dwyer MA, Gurski LA (2017) Bladder Cancer, version 5.2017, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 15:1240–1267. https://doi.org/10.6004/jnccn.2017.0156

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and Validation of a Contrast-Enhanced US VI-RADS for Evaluating Muscle Invasion in Bladder Cancer;Radiology;2024-09-01

2. Performance of 18F-FDG PET/MRI and its parameters in staging and neoadjuvant therapy response evaluation in bladder cancer;iScience;2024-05

3. Budgetary Impact of Including the Urinary Genomic Marker Cxbladder Detect in the Evaluation of Microhematuria Patients;Urology Practice;2024-01

4. Can the Vesical Imaging Reporting and Data System (VI-RADS) score be applied in conventional ultrasound and contrast-enhanced ultrasound to differentiate muscle-invasive bladder cancer?;Medical Ultrasonography;2023-03-30

5. The Role of Imaging in Tumor Staging and Response Assessment: Envisaging an Application for the Next-Generation Trials;Neoadjuvant Immunotherapy Treatment of Localized Genitourinary Cancers;2022